Tag Archives: Cancer

Lunit’s AI solution for breast cancer detection gets CE certification

Lunit, a medical AI company specializing in developing AI solutions for radiology and oncology, announced that its AI solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software, which was certified on 26 May, is now commercially available across the European Economic Area.  Lunit INSIGHT MMG was first introduced at the… Read More »

More sexual partners, more cancer?

Two headlines caught my eye recently: The relationship between chronic diseases and number of sexual partners: an exploratory analysis and Study warns more sex might mean higher likelihood for cancer It may be hard to believe, but both of these refer to same medical research. I’m not sure which one I like better. The first… Read More »

Yoga Poses for Cancer Recovery

Yoga is a highly rated post-surgery cancer care technique. Every cancer survivor will choose to talk with their doctor about the best practices for their unique condition. As a trainer, your best shot lies in offering standard practices. In that case, have a credible tech company such as Gymcatch install a fitness instructor software to… Read More »

FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer

FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer Print this page Morris Plains, N.J., April 22, 2020 — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy™ (sacituzumab govitecan-hziy) for the treatment… Read More »

FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy

Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »

How one bit of medical jargon fuels public confusion about cancer treatments

Most new cancer treatments haven’t been proven to help patients live longer or feel better. Instead they delay the growth of tumors — which may be faster to measure but doesn’t necessarily indicate a tangible benefit for patients. But you wouldn’t grasp that sobering fact from some recent news coverage: A headline in the UK’s… Read More »